Immunotherapy of Malignancy byIn VivoGene Transfer Into Tumors

Human Gene Therapy - United States
doi 10.1089/hum.1992.3.4-399
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Mary Ann Liebert Inc

Related search

DirectIn VivoGene Transfer to Airway Epithelium Employing Adenovirus–Polylysine–DNA Complexes

Human Gene Therapy
Molecular MedicineGeneticsMolecular Biology
1993English

Immunotherapy for Pediatric Brain Tumors

Neuroimmunology and Neuroinflammation
NeurologyImmunology
2018English

Combinational Immunotherapy for Established Tumors With Engineered Tumor Vaccines and Adenovirus-Mediated Gene Transfer

Cancer Gene Therapy
Cancer ResearchMolecular MedicineMolecular Biology
2000English

Advances in Cancer Immunotherapy in Solid Tumors

Cancers
Cancer ResearchOncology
2016English

Human-Specific Cystic Fibrosis Transmembrane Conductance Regulator Antibodies DetectIn VivoGene Transfer to Ovine Airways

American Journal of Respiratory Cell and Molecular Biology
Respiratory MedicinePulmonaryClinical BiochemistryCell BiologyMolecular Biology
2006English

505. Novel VSV-Based Immunotherapy for Brain Tumors

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2013English

EZH2 Is a Sensitive Marker of Malignancy in Salivary Gland Tumors

Diagnostic Pathology
Forensic MedicineMedicinePathologyHistology
2015English

A Deep Dive Into Immunotherapy Resistance

Cancer Discovery
Oncology
2018English

Colony-Stimulating Factor 1 Promotes Progression of Mammary Tumors to Malignancy

Journal of Experimental Medicine
MedicineAllergyImmunology
2001English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy